Regeneron Pharmaceuticals, Inc. (REGN) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 18.21B | 18.02B | 17.98B | 16.86B | 17.57B | 18.66B | 19.33B | 19.08B | 18.87B | 19.48B | 18.63B | 16.92B |
| Cash & Short-Term Investments | 8.75B | 8.61B | 8.44B | 7.47B | 8.35B | 9.01B | 9.8B | 9.81B | 10.52B | 10.84B | 9.91B | 8.93B |
| Cash Only | 2.96B | 3.12B | 2.51B | 2B | 3.09B | 2.49B | 2.01B | 1.92B | 2.6B | 2.73B | 2.15B | 1.94B |
| Short-Term Investments | 5.79B | 5.49B | 5.94B | 5.47B | 5.26B | 6.52B | 7.78B | 7.89B | 7.92B | 8.11B | 7.76B | 6.99B |
| Accounts Receivable | 5.73B | 5.74B | 5.69B | 5.61B | 5.56B | 6.21B | 6.11B | 5.72B | 5.22B | 5.67B | 5.58B | 5.12B |
| Days Sales Outstanding | 143.19 | 135.34 | 138.42 | 138.28 | 174.92 | 149.55 | 146.19 | 140.32 | 157.54 | 150.71 | 146.45 | 147.53 |
| Inventory | 3.1B | 3.2B | 3.25B | 3.21B | 3.19B | 3.09B | 3.02B | 2.87B | 2.71B | 2.58B | 2.56B | 2.51B |
| Days Inventory Outstanding | 423.81 | 507.94 | 569.71 | 549.06 | 608.63 | 496.72 | 551.85 | 529.52 | 555.42 | 376.02 | 430.43 | 441.78 |
| Other Current Assets | 0 | 474.8M | 595.6M | 574.3M | 468.9M | 349.2M | 412M | 681.9M | 414.9M | 386.6M | 574.7M | 366.3M |
| Total Non-Current Assets | 22.66B | 22.54B | 22.19B | 21.36B | 19.97B | 19.1B | 18.11B | 17.01B | 15.5B | 13.6B | 13.53B | 13.73B |
| Property, Plant & Equipment | 5.27B | 5.12B | 5B | 4.84B | 4.69B | 4.6B | 4.44B | 4.31B | 4.23B | 4.15B | 4.01B | 3.92B |
| Fixed Asset Turnover | 0.69x | 0.77x | 0.76x | 0.77x | 0.65x | 0.84x | 0.85x | 0.83x | 0.75x | 0.84x | 0.85x | 0.81x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.29B | 1.26B | 1.38B | 1.35B | 1.17B | 1.15B | 1.12B | 1.1B | 1.06B | 1.04B | 1.02B | 953M |
| Long-Term Investments | 9.79B | 10.26B | 10.29B | 10.06B | 9.28B | 8.9B | 8.49B | 7.72B | 6.98B | 5.4B | 5.78B | 6.33B |
| Other Non-Current Assets | 2.13B | 1.82B | 1.67B | 1.54B | 1.39B | 1.14B | 1.04B | 993.8M | 470.2M | 444.1M | 409.9M | 393.2M |
| Total Assets | 40.87B | 40.56B | 40.17B | 38.22B | 37.55B | 37.76B | 37.44B | 36.09B | 34.37B | 33.08B | 32.16B | 30.66B |
| Asset Turnover | 0.09x | 0.10x | 0.10x | 0.10x | 0.08x | 0.10x | 0.10x | 0.10x | 0.09x | 0.11x | 0.11x | 0.10x |
| Asset Growth % | 8.85% | 7.41% | 7.28% | 5.91% | 9.24% | 14.14% | 16.41% | 17.71% | 14.34% | 13.23% | 16.21% | 12.69% |
| Total Current Liabilities | 5.11B | 4.37B | 4.43B | 3.67B | 3.57B | 3.94B | 3.66B | 3.51B | 3.58B | 3.42B | 3.6B | 3.1B |
| Accounts Payable | 1.03B | 939M | 903.8M | 723.9M | 705.5M | 789.5M | 497.3M | 561.7M | 671.3M | 606.6M | 536.6M | 547.3M |
| Days Payables Outstanding | 132.17 | 145 | 143.55 | 122.67 | 144.9 | 104.69 | 99.19 | 116.83 | 134.04 | 83.59 | 92.03 | 102.72 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 636.2M | 553M | 545.6M | 481.9M | 619.3M | 627.7M | 627.2M | 586M | 516.7M | 458.9M | 417.3M | 381.1M |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 3.57x | 4.13x | 4.06x | 4.60x | 4.93x | 4.73x | 5.28x | 5.44x | 5.27x | 5.69x | 5.18x | 5.45x |
| Quick Ratio | 2.96x | 3.39x | 3.33x | 3.72x | 4.03x | 3.95x | 4.46x | 4.62x | 4.51x | 4.94x | 4.47x | 4.64x |
| Cash Conversion Cycle | 434.83 | 498.27 | 564.58 | 564.67 | 638.65 | 541.57 | 598.84 | 553.02 | 578.93 | 443.14 | 484.85 | 486.59 |
| Total Non-Current Liabilities | 4.34B | 4.93B | 4.79B | 4.61B | 4.59B | 4.46B | 4.46B | 4.37B | 3.8B | 3.68B | 3.66B | 3.54B |
| Long-Term Debt | 1.99B | 1.99B | 1.99B | 1.99B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B |
| Capital Lease Obligations | 0 | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 720M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.13B | 2.02B | 1.86B | 1.7B | 1.67B | 1.57B | 1.54B | 1.46B | 908.5M | 854.1M | 832.4M | 716.8M |
| Total Liabilities | 9.45B | 9.3B | 9.21B | 8.28B | 8.16B | 8.41B | 8.12B | 7.88B | 7.38B | 7.11B | 7.26B | 6.64B |
| Total Debt | 2.71B | 2.71B | 2.71B | 2.71B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B |
| Net Debt | -256.4M | -412.2M | 199.1M | 709.3M | -385.4M | 216.2M | 692.2M | 782.9M | 101.3M | -27.1M | 550.3M | 765M |
| Debt / Equity | 0.09x | 0.09x | 0.09x | 0.09x | 0.09x | 0.09x | 0.09x | 0.10x | 0.10x | 0.10x | 0.11x | 0.11x |
| Debt / EBITDA | 3.53x | 2.64x | 2.33x | 2.23x | 3.76x | 2.42x | 2.08x | 2.27x | 3.12x | 2.32x | 2.05x | 2.41x |
| Net Debt / EBITDA | -0.33x | -0.40x | 0.17x | 0.58x | -0.54x | 0.19x | 0.53x | 0.66x | 0.12x | -0.02x | 0.42x | 0.68x |
| Interest Coverage | 65.43x | 86.55x | 92.36x | 422.86x | 105.02x | 92.25x | 109.19x | 111.01x | 44.52x | 63.71x | 63.40x | 58.30x |
| Total Equity | 31.42B | 31.26B | 30.96B | 29.94B | 29.39B | 29.35B | 29.33B | 28.21B | 26.99B | 25.97B | 24.9B | 24.02B |
| Equity Growth % | 6.93% | 6.48% | 5.56% | 6.14% | 8.88% | 13.02% | 17.75% | 17.44% | 14.88% | 14.6% | 16.17% | 16.1% |
| Book Value per Share | 291.77 | 290.76 | 288.79 | 275.68 | 264.28 | 257.94 | 252.37 | 244.42 | 234.50 | 228.23 | 219.62 | 210.87 |
| Total Shareholders' Equity | 31.42B | 31.26B | 30.96B | 29.94B | 29.39B | 29.35B | 29.33B | 28.21B | 26.99B | 25.97B | 24.9B | 24.02B |
| Common Stock | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K |
| Retained Earnings | 36.42B | 35.8B | 35.05B | 33.68B | 32.38B | 31.67B | 30.76B | 29.41B | 27.98B | 27.26B | 26.1B | 25.09B |
| Treasury Stock | -19.41B | -18.61B | -17.94B | -17.28B | -16.22B | -15.17B | -14.19B | -13.46B | -12.86B | -12.56B | -12.27B | -11.77B |
| Accumulated OCI | 11.9M | 77.5M | 69M | 52.5M | 29.1M | -7.9M | 60.2M | -69.9M | -77.2M | -80.9M | -176.8M | -197.7M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |